Metraipolis › archive › dc_ea684e09f8f0

Hepatotoxicity of new-generation ALK inhibitors versus crizotinib in patients with non-small cell lung cancer: A systematic review and meta-analysis — Europe PMC PMID:41623453

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41623453
DOI
10.1016/j.isci.2025.114613
License (as archived)
solo-consultazione
Archived
2026-11-07T03:08:28.137Z
SHA-256 of the archived text
7d4fef8a510fdf6d88c118c596a9128e67325c3b8616f2919b26bed160aed4f2
Stable URL of this page
https://metraipolis.com/documento/dc_ea684e09f8f0

How to cite

Hepatotoxicity of new-generation ALK inhibitors versus crizotinib in patients with non-small cell lung cancer: A systematic review and meta-analysis — Europe PMC PMID:41623453 — Europe PMC (en), https://europepmc.org/article/MED/41623453 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea684e09f8f0 (Metraipolis archive dc_ea684e09f8f0, sha256 7d4fef8a510fdf6d88c118c596a9128e67325c3b8616f2919b26bed160aed4f2)
BibTeX
@misc{dcea684e09f8f0,
  title = {Hepatotoxicity of new-generation ALK inhibitors versus crizotinib in patients with non-small cell lung cancer: A systematic review and meta-analysis — Europe PMC PMID:41623453},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41623453},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea684e09f8f0; sha256 7d4fef8a510fdf6d88c118c596a9128e67325c3b8616f2919b26bed160aed4f2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41623453. Agents can read the archived copy with the MCP tool read_document.